Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Médium: Artigo
Jazyk:Russo
Vydáno: «FIRMA «SILICEA» LLC 2004-12-01
Edice:Российский кардиологический журнал
Témata:
arterial hypertension
metabolic syndrome
cardioprotective effects
rilmenidine
On-line přístup:https://russjcardiol.elpub.ru/jour/article/view/2326
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky